Comparison of functional proteomic analyses of human breast cancer cell lines T47D and MCF7

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Aka, Juliette Adjo ^a,b   Lin, Sheng Xiang ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN D; CYCLIN D3; CYCLINE; HEAT SHOCK PROTEIN 27; INTERLEUKIN 10; NITRILASE; NITRILASE HOMOLOG 2; PROHIBITIN; PROTEIN S 100; PROTEIN S100 A14; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NF X1; UNCLASSIFIED DRUG; MESSENGER RNA;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL STRAIN MCF 7; CELL STRAIN T47D; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE; BREAST TUMOR; CELL CYCLE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CATHEPSIN B; CATHEPSIN D; CELL CYCLE; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MASS SPECTROMETRY; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEOMICS; RNA, MESSENGER;

EID: 84863128254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031532     Document Type: Article

References (20)

1. Sasco AJ, (2003) Breast Cancer and the Environment. Horm Res 60 (Suppl 3): 50.
2. ESHRE Capri Workshop Group (2004) Hormones and breast cancer. Hum Reprod Update 10: 281-293.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
4. Canadian Cancer Society's Steering Committee (2009) Canadian Cancer Statistics 2009. Toronto, Canada, Canadian Cancer Society.
5. Husen B, Huhtinen K, Saloniemi T, Messinger J, Thole, et al. (2006) Human hydroxysteroid (17-beta) dehydrogenase 1 expression enhances estrogen sensitivity of MCF-7 breast cancer cell xenografts. Endocrinology 147: 5333-5339.
6. Day JM, Foster PA, Tutill HJ, Parsons MF, Newman SP, et al. (2008) 17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer. Int J Cancer 122: 1931-1940.
7. Aka JA, Mazumdar M, Chen CQ, Poirier D, Lin SX, (2010) 17β-hydroxysteroid dehydrogenase Type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production. Mol Endocrinol 24: 832-845.
8. Huber M, Bahr I, Krätzschmar JR, Becker A, Müller EC, et al. (2004) Comparison of Proteomic and Genomic Analyses of the Human Breast Cancer Cell Line T47D and the Antiestrogen-resistant Derivative T47D-r. Mo Cell Proteomics 3: 43-55.
9. Bianchi L, Canton C, Bini L, Orlandi R, Ménard S, et al. (2005) Protein profile changes in the human breast cancer cell line MCF-7 in response to SEL1L gene induction. Proteomics 5: 2433-2442.
10. Sarvaiya HA, Yoon JH, Lazar IM, (2006) Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation. Rapid Commun Mass Spectrom 20: 3039-3055.
11. Shevchenko A, Wilm M, Vorm O, Mann M, (1996) Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Analytical Chemistry 68: 850-858.
12. Havlis J, Thomas H, Sebela M, Shevchenko A, (2003) Fast-Response Proteomics by Accelerated In-Gel Digestion of Proteins. Anal Chem 75: 1300-1306.
13. Luu-The V, Paquet N, Calvo E, Cumps J, (2005) Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques 38: 287-293.
14. Journet A, Ferro M, (2004) The potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer. Mass Spectrom Rev 23: 393-442.
15. Gast MC, Schellens JH, Beijnen JH, (2008) Clinical proteomics in breast cancer: a review. Breast Cancer Res Treat 116: 17-29.
16. Faust PL, Wall DA, Perara E, Lingappa VR, Kornfeld S, (1987) Expression of human cathepsin D in Xenopus oocytes: phosphorylation and intracellular targeting. J Cell Biol 105: 1937-1945.
17. Liaudet-Coopman E, Beaujouin M, Derocq D, Garcia M, Glondu-Lassis M, et al. (2006) Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett 237: 167-179.
18. Parl FF, (2000) Estrogen, estrogen receptor and breast cancer. Biomedical and Health Research Vol 36 Amsterdam IOS Press.
19. Aspinall SR, Stamp S, Davison A, Shenton BK, Lennard TW, (2004) The proliferative effects of 5-androstene-3 beta,17 beta-diol and 5 alpha-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines. J Steroid Biochem Mol Biol 88: 37-51.
20. Greeve MA, Allan RK, Harvey JM, Bentel JM, (2004) Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1). J Mol Endocrinol 32: 793-810.